Steep Hill collaborated with the University of Technology, Jamaica at the recent Rastafari RootzFest, to leverage the Steep Hill Express test to provide accurate cannabis potency testing for the event.
Abattis Bioceuticals has announced the successful completion of experiments utilizing column chromatography for cannabinoid extraction.
Knowing more about the interaction between cannabinoids and inflammation in HIV patients may help us to develop drugs specifically to maintain their mental function.
Most providers willing to consider medical marijuana use in children with cancer.
EVIO has announced that it has signed a non-binding letter of intent to acquire 60% of C3 Labs.
Shimadzu Scientific Instruments (SSI) and Restek Corporation have entered a partnership that enables the sales of Restek consumables by SSI.
There is currently no drug treatment for sleep apnea, a sleep breathing disorder affecting about 30 million individuals in the United States.
Patients believe using marijuana helps them with their symptoms, but the study’s results could indicate the opposite is true for those in addiction treatment.
This announcement was included in the approval and release of edits to Bill C-45 which also outlined a deadline stating that edibles will be available to the public, alongside the marijuana adult use legalization, set to launch in 2018.